Mark T. Osterman, M.D., MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Attending Physician,, Penn Medicine at Radnor, Radnor, PA
Attending Physician, , Penn Presbyterian Medical Center, Philadelphia, PA
Attending Physician, , Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Medicine
Contact information
Presbyterian Medical Center
218 Wright Saunders Bldg.
39th & Market Streets
Philadelphia, PA 19104
218 Wright Saunders Bldg.
39th & Market Streets
Philadelphia, PA 19104
Office: 215-662-8900
Fax: 215-662-0950
Fax: 215-662-0950
Email:
mark.osterman@uphs.upenn.edu
mark.osterman@uphs.upenn.edu
Publications
Education:
BA (Chemistry)
Harvard University, 1995.
MD (Medicine)
Harvard Medical School, 1999.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2008.
BA (Chemistry)
Harvard University, 1995.
MD (Medicine)
Harvard Medical School, 1999.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2008.
Post-Graduate Training
Intern in Internal Medicine, Brigham and Women's Hospital, 1999-2000.
Resident in Internal Medicine, Brigham and Women's Hospital, 2000-2002.
Fellow in Gastroenterology, University of Pennsylvania, 2002-2005.
Fellow in Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2003-2005.
Permanent linkIntern in Internal Medicine, Brigham and Women's Hospital, 1999-2000.
Resident in Internal Medicine, Brigham and Women's Hospital, 2000-2002.
Fellow in Gastroenterology, University of Pennsylvania, 2002-2005.
Fellow in Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2003-2005.
Selected Publications
Osterman MT, Lichtenstein GR: Reform of an aminosalicylate: an example of the importance of pill burden on medical compliance rates. Methods and Findings in Experimental and Clinical Pharmacology 31: 41-46, 2009.Osterman MT, Lichtenstein GR: Treatment of perianal Crohn's fistulae. Pediatric Inflammatory Bowel Disease. Markowitz J, Mamula P, Baldassano R (eds.). Springer Science Business Media, LLC New York City, 2008.
Blonski W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR: Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? Scandinavian Journal of Gastroenterology 43: 698-703, 2008.
Jones DT, Osterman MT, Bewtra M, Lewis JD: Passive smoking and inflammatory bowel disease: a meta-analysis. American Journal of Gastroenterology 103: 2382-2393, 2008.
Osterman MT: Adalumumab cuts hospitalizations in Crohn's patients. GI & Hepatology News 2(11): 6, 2008.
Osterman MT, Lewis JD, Aberra F: Overview of common design features for clinical trials. Inflammatory Bowel Disease. Targan S, Shanahan F, Karp L (eds.). 2008.
Osterman, MT, Lichtenstein GR: Current and future anti-TNF therapy for inflammatory bowel disease. Current Treatment Options in Gastroenterology 10: 195-207, 2007.
Katz KA, Dick SE, Osterman MT, Junkins-Hopkins JM: Perianal skin tags in a Crohn's disease patient with a subclinical rectal stricture. Cutis 80: 429-431, 2007.
Osterman MT, Lichtenstein GR: Infliximab in fistulizing Crohn's disease. Gastroenterology Clinics of North America 35(4): 795-820, December 2006.
Osterman MT, Lichtenstein GR: 6-Mercaptopurine and azathioprine in Crohn's disease. Treatment of Inflammatory Bowel Disease. Lichtenstein GR (eds.). 2006.
